CHE Stock Analysis: Buy, Sell, or Hold?
CHE - Chemed Corporation
$540.57
8.32 (1.56%)
▲
5d:
+6.13%
30d:
+10.4%
90d:
+28.05%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 28, 2026
0d
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CHE trades at premium valuation expecting 6.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CHE trades at premium valuation expecting 6.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$631.06
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$391.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $540.57, which is considered extended relative to its 30-day fair value range of $474.55 to $520.64. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.8) compared to its historical average (16.6). At these levels, the market is pricing in 6.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CHE is in a strong uptrend. The price is approaching resistance at $551.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CHE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $474.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CHE is in a strong uptrend. The price is approaching resistance at $551.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CHE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $474.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$474.55 -
$520.64
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 10.9% above Wall St target ($474.00)
- NEUTRAL: Trading at premium valuation - market expects 6.1% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$474.55 -
$520.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$493.78
Resistance Level
$551.68
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.80
Wall Street Target
$474.00
(-10.9%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
43.7%
Profit Margin
10.6%
Valuation Premium vs History
+6.1% premium
PE vs Historical
19.8 vs 16.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.1%
(market-implied from PE analysis)
1-Year Target
$564.72
(+6%)
2-Year Target
$599.17
(+13%)
3-Year Target
$635.71
(+19%)
3-Yr Target (if PE normalizes)
(PE: 20→17)
PE COMPRESSION
$533.00
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 10.4%)
$750.55
(+41%)
Base:
(SPY PE: 19.8, Growth: 10.4%)
$716.85
(+35%)
Bear:
(PE: 16.6, Growth: 10.4%)
$601.02
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 26.87 | Current EPS (TTM): $19.90
Bull Case
$794.68
(+49%)
Analyst growth 35.1%, PE expands to 29.6
Base Case
$722.44
(+36%)
Market implied 35.1%, PE stable at 26.9
Bear Case
$363.66
(-32%)
Severe decline -20.0%, PE contracts to 22.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 03, 2026 3:56 PM ET
Data refreshes hourly during market hours. Next update: 4:56 PM
Data refreshes hourly during market hours. Next update: 4:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin J Mcnamara
SELL
2000 shares
2026-03-12
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |